Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Enrolling by invitation Phase 3 Interventional

Phase 3, Open Label Extension Study of ACP-204 in Lewy Body Dementia Psychosis

ClinicalTrials.gov ID: NCT07095465

Public ClinicalTrials.gov record NCT07095465. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 19, 2026, 9:07 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

52-Week, Phase 3, Open-Label Extension Study of ACP-204 in Adults With Lewy Body Dementia Psychosis (LBDP)

Study identification

NCT ID
NCT07095465
Recruitment status
Enrolling by invitation
Study type
Interventional
Phase
Phase 3
Lead sponsor
ACADIA Pharmaceuticals Inc.
Industry
Enrollment
126 participants

Conditions and interventions

Interventions

  • ACP-204 Drug

Drug

Eligibility (public fields only)

Age range
55 Years to 84 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 13, 2025
Primary completion
Jan 31, 2029
Completion
Feb 28, 2029
Last update posted
Apr 21, 2026

2025 – 2029

United States locations

U.S. sites
11
U.S. states
6
U.S. cities
9
Facility City State ZIP Site status
Humanity Clinical Research, Corp Aventura Florida 33180
K2 Summit Research Lady Lake Florida 32159
Homestead Associates in Research Inc Miami Florida 33032
Advanced Clinical Research Network, Corp Miami Florida 33135
MediClear Medical & Research Center, Inc. Miami Florida 33165
Health Synergy Clinical Research, LLC West Palm Beach Florida 33407
Hawaii Pacific Neuroscience Honolulu Hawaii 96817
University of Kansas Medical Center Research Institute Inc. Kansas City Kansas 66160
The Ohio State University, Energy Advancement and Innovation Center Columbus Ohio 43210
The Movement Disorder Clinic of Oklahoma Tulsa Oklahoma 74136
R and H Clinical Research Stafford Texas 77477

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT07095465, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 21, 2026 · Synced May 19, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT07095465 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →